Medulloblastoma is the most common malignant brain tumor in children. In addition to sporadic cases, medulloblastoma may occur in association with cancer predisposition syndromes. This review aims to provide a complete description of inherited cancer syndromes associated with medulloblastoma. We examine their epidemiological, clinical, genetic, and diagnostic features and therapeutic approaches, including their correlation with medulloblastoma. Furthermore, according to the most recent molecular advances, we describe the association between the various molecular subgroups of medulloblastoma and each cancer predisposition syndrome. Knowledge of the aforementioned conditions can guide pediatric oncologists in performing adequate cancer surveillance. This will allow clinicians to promptly diagnose and treat medulloblastoma in syndromic children, forming a team with all specialists necessary for the correct management of the other various manifestations/symptoms related to the inherited cancer syndromes.

Carta, R., Del Baldo, G., Miele, E., Po, A., Besharat, Z.m., Nazio, F., et al. (2020). Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era. FRONTIERS IN ONCOLOGY, 10 [10.3389/fonc.2020.566822].

Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era

Nazio F.;
2020-01-01

Abstract

Medulloblastoma is the most common malignant brain tumor in children. In addition to sporadic cases, medulloblastoma may occur in association with cancer predisposition syndromes. This review aims to provide a complete description of inherited cancer syndromes associated with medulloblastoma. We examine their epidemiological, clinical, genetic, and diagnostic features and therapeutic approaches, including their correlation with medulloblastoma. Furthermore, according to the most recent molecular advances, we describe the association between the various molecular subgroups of medulloblastoma and each cancer predisposition syndrome. Knowledge of the aforementioned conditions can guide pediatric oncologists in performing adequate cancer surveillance. This will allow clinicians to promptly diagnose and treat medulloblastoma in syndromic children, forming a team with all specialists necessary for the correct management of the other various manifestations/symptoms related to the inherited cancer syndromes.
2020
Pubblicato
Rilevanza internazionale
Recensione
Esperti anonimi
Settore MED/04 - PATOLOGIA GENERALE
English
cancer genes; cancer predisposition; cancer syndromes; hereditary neoplastic syndromes; medulloblastoma; pediatric brain tumors
Carta, R., Del Baldo, G., Miele, E., Po, A., Besharat, Z.m., Nazio, F., et al. (2020). Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era. FRONTIERS IN ONCOLOGY, 10 [10.3389/fonc.2020.566822].
Carta, R; Del Baldo, G; Miele, E; Po, A; Besharat, Zm; Nazio, F; Colafati, Gs; Piccirilli, E; Agolini, E; Rinelli, M; Lodi, M; Cacchione, A; Carai, A;...espandi
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/312412
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 18
social impact